Impaired modulation of circadian rhythms in patients with diabetes mellitus: A risk factor for cardiac thrombotic events?

Chronobiology International

Volumn 18, Issue 1, 2001, Pages 109-121

  Aronson, D ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Autonomic neuropathy; Circadian rhythm; Diabetes mellitus; Fibrinolysis; Myocardial infarction

Indexed keywords

FIBRINOLYTIC FACTOR;

ARTICLE; ATHEROSCLEROTIC PLAQUE; AUTONOMIC NEUROPATHY; BLOOD PRESSURE; CIRCADIAN RHYTHM; DIABETES MELLITUS; FIBRINOLYSIS; HEART INFARCTION; HEMODYNAMICS; HUMAN; HYPERCOAGULABILITY; INTRACARDIAC THROMBOSIS; RISK FACTOR; SYMPATHETIC TONE; THROMBOGENESIS;

ARTERIOSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; HUMANS; MYOCARDIAL INFARCTION; RUPTURE, SPONTANEOUS; SYMPATHETIC NERVOUS SYSTEM; THROMBOSIS; VAGUS NERVE;

THROMBUS;

EID: 0035129912     PISSN: 07420528     EISSN: None     Source Type: Journal    
DOI: 10.1081/CBI-100001175     Document Type: Article

References (96)

1. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association
2. Consensus statement: Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes
3. Plasma corticosterone, motor activity and metabolic circadian patterns in streptozotocin-induced diabetic rats
4. Roles of circadian rhythmicity and sleep in human glucose regulation
5. Altered circadian responses to light in streptozotocin-induced diabetic mice
6. Circadian variation in the frequency of onset of acute myocardial infarction
7. Increased morning incidence of myocardial infarction in the ISAM study: Absence with prior beta-adrenergic blockade
8. Diurnal variation of and activity during the onset of stroke
9. Circadian variation in pain onset in unstable angina pectoris
10. Circadian variation in the frequency of sudden cardiac death
11. Timing of sudden death in patients with heart failure
12. The pathogenesis of coronary artery disease and the acute coronary syndromes. Part I
13. The pathogenesis of coronary artery disease and the acute coronary syndromes. Part II
14. Triggers, acute risk factors and vulnerable plaques: The lexicon of a new frontier
15. Circadian variation and triggers of onset of acute cardiovascular disease
16. From a static to a dynamic concept of risk: The circadian epidemiology of cardiovascular events
17. Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects
18. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death
19. A diurnal rhythm in plasma renin activity in man
20. Diurnal changes in coronary blood flow in conscious dogs
21. Sympathetic activity as the cause of the morning increase in cardiac events. A likely culprit, but the evidence remains circumstantial
22. Morphodynamic interpretation of acute coronary thrombosis, with special reference to volcano-like eruption of atheromatous plaque caused by coronary artery spasm
23. Plaque fissuring - The cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina
24. Thrombi in acute coronary syndromes: Revisited and revised
25. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
26. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction
27. Platelet hyperreactivity and prognosis in survivors of myocardial infarction
28. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
29. Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke
30. Diurnal variation of the fibrinolytic system
31. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1)
32. Morning increase in platelet aggregability. Association with assumption of the upright posture
33. Circadian variations in blood coagulation parameters, alpha- antitrypsin antigen and platelet aggregation and retention in clinically healthy subjects
34. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex
35. Circadian rhythm of human blood viscosity
36. Circadian changes in anticoagulant effect of heparin infused at a constant rate
37. Circadian variation in the success rate of intracoronary thrombolysis for acute myocardial infarction
38. Circadian variation in the efficacy of tissue-type plasminogen activator
39. Circadian variations of onset of acute myocardial infarction and efficacy of thrombolytic therapy
40. Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT Study)
41. Acute myocardial infarction in a large industrial population: Report of a 6-year study of 1,356 cases
42. Long-term prognosis after myocardial infarction in men with diabetes
43. Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction
44. Subgroups of patients with atypical circadian patterns of symptom onset in acute myocardial infarction
45. Six-year survival after coronary thrombolysis and early revascularization for acute myocardial infarction
46. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction
47. Events in the cardiac arrhythmia suppression trial: Baseline predictors of mortality in placebo-treated patients
48. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty
49. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute percutaneous transluminal coronary angioplasty registry
50. Results of percutaneous coronary, angioplasty in patients <40 years of age
51. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
52. Differing circadian patterns of symptom onset in subgroups of patients with acute myocardial infarction
53. Lack of diurnal variation in the onset of non-q wave infarction
54. Morning peak in the incidence of myocardial infarction: Experience in the ISIS-2 trial
55. Absence of circadian variation in the onset of acute myocardial infarction in diabetic subjects
56. Modification of the circadian variation of symptom onset of acute myocardial infarction in diabetes mellitus
57. Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy
58. Neuropathy profile of diabetic patients in a pancreas transplantation program
59. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten-year follow-up from the diagnosis
60. Impaired circadian modulation of sympathovagal activity in diabetes. A possible explanation for altered temporal onset of cardiovascular disease
61. Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy
62. Power spectral analysis of heart-rate variations improves assessment of diabetic cardiac autonomic neuropathy
63. Muscle sympathetic nerve activity is reduced in IDDM before overt autonomic neuropathy
64. Myocardial m-[123I]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function
65. Circadian patterns of heart rate variability, fibrinolytic activity, and hemostatic factors in type I diabetes mellitus with cardiac autonomic neuropathy
66. Blood pressure during normal daily activities, sleep, and exercise. Comparison of values in normal and hypertensive subjects
67. Dippers and non-dippers
68. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension
69. Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events
70. Circadian variation of blood-pressure
71. Autonomic nervous function in non-dipper essential hypertensive subjects. Evaluation by power spectral analysis of heart rate variability
72. Circadian variation of blood pressure in autonomic failure
73. National high blood pressure education program working group report on hypertension and diabetes
74. Consensus statement on the treatment of hypertension in diabetes
75. Recognition of hypertension and abnormal blood pressure burden with ambulatory blood pressure recordings in type I diabetes mellitus
76. Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients
77. On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy
78. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects
79. Altered blood pressure during sleep in normotensive subjects with type I diabetes
80. Circadian rhythm of arterial blood pressure and albuminuria in diabetic nephropathy
81. Pressor factors and responsiveness in hypertension accompanying diabetes mellitus
82. Central role of sodium in hypertension in diabetic subjects
83. The clinical significance of diurnal blood pressure variations. Dippers and nondippers
84. Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience
85. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus
86. PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria
87. Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients
88. Platelet abnormalities in diabetes mellitus
89. Platelet hyperreactivity in diabetics: Relation to time of onset of acute myocardial infarction
90. Mechanisms underlying the morning increase in platelet aggregation: A flow cytometry study
91. Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes
92. Diabetes and atherosclerosis: An epidemiologic view
93. Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration
94. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction
95. Daytime fluctuations of plasminogen activator inhibitor 1 (PAI-1) in populations with high PAI-1 levels
96. Blood fibrinolytic activity in man. Diurnal variation and the response to varying intensities of exercise